St. Jude Vascular Closure Business Continues To Top 50% Sales Growth
This article was originally published in The Gray Sheet
Executive Summary
Widespread acceptance of femoral artery closure devices pushed second-quarter sales of St. Jude Medical's Angio-Seal vascular closure device 52% versus the year-ago period, driving the firm's overall second-quarter earnings by almost 12% to $336 mil.